Number of items: 14.
2024
Main, A., Mary, S. , Sin, Y. Y. , Wright, T. A., Ling, J., Blair, C. M., Smith, G. L. , Fuller, W. and Baillie, G. S.
(2024)
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenaline.
International Journal of Biochemistry and Cell Biology, 176,
106668.
(doi: 10.1016/j.biocel.2024.106668)
(PMID:39321569)
Sin, Y. Y. et al.
(2024)
Beta-amyloid interacts with and activates the longform phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability.
FEBS Letters, 598(13),
pp. 1591-1604.
(doi: 10.1002/1873-3468.14902)
(PMID:38724485)
Cooke, S. F. et al.
(2024)
Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC.
Scientific Reports, 14,
8998.
(doi: 10.1038/s41598-024-59451-3)
(PMID:38637546)
Cooke, S. F. and Blair, C. M.
(2024)
Exploiting c-RAF dependency in RAS mutant cancer: Beyond catalytic activity.
Expert Review of Anticancer Therapy, 24(3-4),
pp. 95-100.
(doi: 10.1080/14737140.2024.2319035)
2023
Brown, A. D., Vergunst, K. L., Branch, M., Blair, C. M., Dupré, D. J., Baillie, G. S. and Langelaan, D. N.
(2023)
Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
Biochimica et Biophysica Acta: Molecular Cell Research, 1870(7),
119520.
(doi: 10.1016/j.bbamcr.2023.119520)
(PMID:37353163)
Wright, T. A., Gemmell, A. O., Tejeda, G. S. , Blair, C. M. and Baillie, G. S.
(2023)
Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target.
International Journal of Biochemistry and Cell Biology, 162,
106453.
(doi: 10.1016/j.biocel.2023.106453)
(PMID:37499270)
Paes, D. et al.
(2023)
Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology.
Cellular and Molecular Life Sciences, 80(7),
178.
(doi: 10.1007/s00018-023-04804-w)
(PMID:37306762)
(PMCID:PMC10261250)
2022
Tibbo, A. J. et al.
(2022)
Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins.
Journal of Molecular and Cellular Cardiology, 165,
pp. 86-102.
(doi: 10.1016/j.yjmcc.2022.01.001)
(PMID:34999055)
(PMCID:PMC8986152)
2021
Mahindra, A. et al.
(2021)
Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction.
PLoS ONE, 16(11),
e0260283.
(doi: 10.1371/journal.pone.0260283)
(PMID:34793553)
(PMCID:PMC8601423)
Morgan, D. C. et al.
(2021)
Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation.
Peptide Science, 113(4),
e24217.
(doi: 10.1002/pep2.24217)
(PMID:33615115)
(PMCID:PMC7883042)
2020
Ling, J., Blair, C. M. and Baillie, G. S.
(2020)
Fibrin Breakdown Assay.
Bio-Protocol, 10(8),
e3585.
(doi: 10.21769/BioProtoc.3585)
Blair, C. M., Ling, J. and Baillie, G. S.
(2020)
Measuring cAMP specific phosphodiesterase activity: a two-step radioassay.
Bio-Protocol, 10(7),
e3581.
(doi: 10.21769/BioProtoc.3581)
(PMID:33659551)
(PMCID:PMC7842805)
2019
Blair, C. M. and Baillie, G. S.
(2019)
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes.
Biochemical Society Transactions, 47(5),
pp. 1405-1414.
(doi: 10.1042/BST20190252)
(PMID:31506329)
Blair, C. M., Walsh, N., Littman, B. H., Marcoux, F. W. and Baillie, G. S.
(2019)
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf.
BMC Cancer, 19,
266.
(doi: 10.1186/s12885-019-5489-4)
(PMID:30909892)
(PMCID:PMC6434832)
This list was generated on Thu Nov 21 03:23:48 2024 GMT.
